Positive serum CEA level (>5 ng/ml) appeared to be more likely with relapse (75% vs 49%, P = 0.047); moreover, different chemotherapies were also associated with tumor recurrence (P < 0.005). This evidence concerns the gene CEACAM5 and neoplasm.